Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P0HT
|
||||
| Former ID |
DAP001047
|
||||
| Drug Name |
Fluorometholone
|
||||
| Synonyms |
Cortilet; Cortisdin; Delmeson; Efflumidex; FML; Fluaton; Flucon; Flumetholon; Fluormetholon; Fluormetholone; Fluormetholonum; Fluoromethalone; Fluorometholonum; Fluorometolona; Fluorometolone; Fluoropos; Loticort; Oxylone; Trilcin; Ursnon; Alcon Brand of Fluorometholone; FML Forte; FML Liquifilm; Fluor Op; Fluoro Ophtal; Fluorometolone [DCIT]; Isdin Brand of Fluorometholone; Isopto Flucon; Novartis Brand of Fluorometholone; PMS Fluorometholone; Pharm Allergan Brand of Fluorometholone; Pharmascience Brand of Fluorometholone; Ursapharm Brand of Fluorometholone; Winzer Brand of Fluorometholone; Allergan Brand 1 of Fluorometholone; Allergan Brand 2 of Fluorometholone; Allergan Brand 3 of Fluorometholone; F0414; U 8614; Component of Neo-Oxylone; FML (TN); FML-S Liquifilm; Flarex (TN); Flucon, Isopto; Fluor-Op; Fluoro-Ophtal; Fluorometholonum [INN-Latin]; Fluorometolona [INN-Spanish]; Fml (TN); Neo-Oxylone; Oxylone (TN); PMS-Fluorometholone; Pharm-Allergan Brand of Fluorometholone; FML S.O.P; Fluor-op (TN); Fluorometholone [INN:BAN:JAN]; Fluorometholone (JP15/USP/INN); Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17-dihydroxy-6alpha-methyl-(8CI); (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; 11beta,17alpha-Dihydroxy-9-fluoro-6-methyl-1,4-pregnadiene-3,20-dione; 9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11-beta,17-dihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione; 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Corticosteroid-responsive inflammation | Approved | [551871] | ||
| Therapeutic Class |
Antiallergic Agents
|
||||
| Company |
Alcon Laboratories
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H29FO4
|
||||
| InChI |
InChI=1S/C22H29FO4/c1-12-9-17-15-6-8-21(27,13(2)24)20(15,4)11-18(26)22(17,23)19(3)7-5-14(25)10-16(12)19/h5,7,10,12,15,17-18,26-27H,6,8-9,11H2,1-4H3/t12-,15-,17-,18-,19-,20-,21-,22-/m0/s1
|
||||
| InChIKey |
FAOZLTXFLGPHNG-KNAQIMQKSA-N
|
||||
| CAS Number |
CAS 426-13-1
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
91286, 220404, 855588, 7848430, 7979244, 8157129, 10321327, 11407278, 11466746, 11467866, 11486592, 14804353, 14902232, 24894996, 29228436, 46505984, 47572923, 47794581, 48393458, 48393459, 49698623, 50019438, 50103940, 50990491, 53786931, 56422125, 57325845, 71822899, 85788043, 87570182, 92125901, 92720066, 99368351, 103770583, 103913807, 104321775, 121363572, 124800816, 126620397, 134338309, 134973988, 135898484, 137008630, 144203991, 144212910, 152034527, 160963672, 162175073, 163835781, 170464629
|
||||
| ChEBI ID |
ChEBI:31625
|
||||
| SuperDrug ATC ID |
C05AA06; D07AB06; D07XB04; D10AA01; S01BA07; S01CB05
|
||||
| SuperDrug CAS ID |
cas=000426131
|
||||
| Target and Pathway | |||||
| Target(s) | Glucocorticoid receptor | Target Info | Binder | [535767] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.